• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Publication
Peer-Reviewed
Evidence-Based OncologyJanuary 2021
Volume 27
Issue 1

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.

Related Videos
Jade E. Jones, MD
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health
Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health
Sarah Anderson, oncology strategy lead director, Novotech
Sarah Anderson, oncology strategy lead director, Novotech
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
Mikael Eriksson, PhD.
Roberto Salgado, MD.
Komal Jhaveri, MD, FACP.
Mei Wei, MD.
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.